DIACC-2010

N/A

Report date: 2024/01/11 14:42:22
NME

Base Information

Drug NameDIACC-2010
Drug Alias NameDIACC-2010DIACC2010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein KIF20A inhibitors
TargetsKinesin-like protein KIF20A
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvexta Bio SA
China Registration ClassN/A

Develop Information

Active CompaniesEvexta Bio SA
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A